T. Joseph Mattingly II, PhD, PharmD, MBA

While DTC pharmacy models offer convenience, they may create cost, access, and guidance barriers for the "working poor."

Experts explain that DTC models could improve medication adherence through convenience and incentives, but higher costs may limit their effectiveness.

The recent reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) comes with an expanded mandate to study the economic impacts of treatments presenting new opportunities for the value assessment research community.